CLINICAL_TRIALS
withdrawal
· 2023-02-02
Clinical Trial Update: Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline [Phase 4]
Summary
Phase 4 trial comparing pregabalin to sertraline for anxiety in epilepsy patients was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rush University Medical Center | Conditions: Epilepsy, Anxiety | Phase 4 | Status: WITHDRAWN